Xbrane Biopharma: Initial Take on Encouraging Results - Redeye
Redeye gives its initial impressions regarding the release of Xbrane’s positive interim data from its phase III study Xplore. Following the scheduled webcast, we will return with a more detailed note.
ANNONS
Redeye gives its initial impressions regarding the release of Xbrane’s positive interim data from its phase III study Xplore. Following the scheduled webcast, we will return with a more detailed note.